Chemical Structure : HBC-12551
Catalog No.: PC-26002Not For Human Use, Lab Use Only.
HBC-12551 is a potent, selective and noncovalent Bruton's tyrosine kinase (BTK) inhibitor with SPR Kd of 0.25 nM.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
HBC-12551 is a potent, selective and noncovalent Bruton's tyrosine kinase (BTK) inhibitor with SPR Kd of 0.25 nM.
HBC-12551 shows potent inhibition of Tyr223 phosphorylation (IC50 = 1.31 nM and IC50 = 2.18 nM, respectively) in HEK293 cells expressing constitutively active wide-type or C481S mutant BTK.
HBC-12551 decreases viability of a panel of malignant B cells (TMD8, TMD8-BTK-C481S, OCI-Ly10, REC-1) with IC50 of 0.95-2.18 nM.
HBC-12551 also significantly inhibited BTK-mediated B cell activation, as indicated by CD69 expression (IC50 = 0.95 nM), in PBMCs.
HBC-12551 (10-20 mg/kg dose (p.o., QD, 14 days)) exhibited great tumor growth inhibition (TGI) efficacy in xenograft mouse models bearing TMD8 and TMD8-BTK-C481S tumors.
| M.Wt | 660.75 | |
| Formula | C34H41FN8O5 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Gang Liu, et al. J Med Chem. 2026 Jan 30. doi: 10.1021/acs.jmedchem.5c02785.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright